Olema Pharmaceuticals’ (OLMA) Outperform Rating Reiterated at Oppenheimer
Oppenheimer restated their outperform rating on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a report released on Wednesday,Benzinga reports. The brokerage currently has a $25.00 price objective on the stock, down from their previous price objective of $30.00. Separately, HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares […]
Oppenheimer restated their outperform rating on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a report released on Wednesday,Benzinga reports. The brokerage currently has a $25.00 price objective on the stock, down from their previous price objective of $30.00. Separately, HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares […]
